Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Contineum Therapeutics
(CTNM) Q1 2025
Earnings
CTNM
Mar 6
Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-3.55
-2.48
-1.42
-0.35
Details
Expected EPS
-0.428
Actual EPS
-0.56
Surprise EPS
-0.13
Surprise Percent
-30.84%
Description
Contineum Therapeutics (CTNM) has reported earnings of -0.56 per share for Q1 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login